donepezil has been researched along with Cerebral Infarction in 3 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to explore the influence factors of gait performance and investigate whether donepezil could improve gait performance in patients with an acute cerebral infarction." | 7.96 | Donepezil Improves Gait Performance in Patients with an Acute Cerebral Infarction: A Prospective Observational Cohort Study. ( Guo, SJ; Huang, DY; Lin, YY; Quan, H; Zhao, YX, 2020) |
| "This study aimed to explore the influence factors of gait performance and investigate whether donepezil could improve gait performance in patients with an acute cerebral infarction." | 3.96 | Donepezil Improves Gait Performance in Patients with an Acute Cerebral Infarction: A Prospective Observational Cohort Study. ( Guo, SJ; Huang, DY; Lin, YY; Quan, H; Zhao, YX, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, YY | 1 |
| Guo, SJ | 1 |
| Quan, H | 1 |
| Zhao, YX | 1 |
| Huang, DY | 1 |
| Gauthier, SG | 1 |
| Sakakibara, R | 1 |
| Uchiyama, T | 1 |
| Hattori, T | 1 |
2 reviews available for donepezil and Cerebral Infarction
| Article | Year |
|---|---|
Alzheimer's disease: the benefits of early treatment.
Topics: Aged; Alzheimer Disease; Cerebral Infarction; Cholinesterase Inhibitors; Donepezil; Humans; Indans; | 2005 |
[Drug treatment for geriatric urinary disorders; current concept].
Topics: Aged; Aged, 80 and over; Amantadine; Cerebral Infarction; Cholinergic Antagonists; Cognition Disorde | 2006 |
1 other study available for donepezil and Cerebral Infarction
| Article | Year |
|---|---|
Donepezil Improves Gait Performance in Patients with an Acute Cerebral Infarction: A Prospective Observational Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Cerebral Infarction; Cohort Studies; Donepezil; Female; Gait; Gait D | 2020 |